1. Investigators using biospecimens under the stewardship of the UMMS CBR should consider adding authors to publications that include results generated from the use of these biospecimens.
a. If a Principal Investigator contributing biospecimens to the UMMS CBR expects to be an author on all publications generated from secondary use of those biospecimens, he or she will indicate this at the initiation of the project with the UMMS CBR. In this event, that Principal Investigator must commit to meeting the criteria for authorship as stated in the UMMS authorship policies referenced in (2) below.
2. The UMMS CBR recognizes the authorship guidance provided by the University of Michigan Medical School. Briefly, authorship should be considered when a person has provided:
a. Significant contributions affecting the direction, scope, or depth of research;
b. Long-term guidance and development of the project;
c. Creative contributions to the project with clear understanding of its goals;
d. Development of methodologies necessary for timely completion of the project; or
e. Data analysis of interpretation vital to the conclusions of the project.
The full University of Michigan Medical School guidance on authorship is available in these policies: University of Michigan Medical School Guidelines for the Responsible Conduct of Research: Guidelines for Authorship; Appropriate Authorship Attribution (Ghostwriting, Guest Authorship) Policy.
3. The UMMS CBR shall provide the names of Principal Investigators on primary studies who should be contacted with respect to authorship on a publication, grant application, or presentation.
4. In the event of a dispute over inclusion or exclusion of a proposed author, the UMMS CBR Governance Committee shall adjudicate. If the proposed author or the publishing Principal Investigator is a member of that committee, he or she shall be recused from voting on that issue.